Moderna ramps up EU COVID jab capacity via Lonza deal

Capacity to supply Moderna's COVID-19 vaccine in Europe could be swelled by around 300 million doses a year, following an agreement to set up a new production line at contract manufacturer

Novartis halts three trials of Beovu eye drug on safety conc...

Prospects for Novartis' ophthalmology drug Beovu have taken another dive after the drugmaker reported toxicity issues in a new phase 3 trial in wet age-related macular degeneration (AMD).

Ashfield Engage acquires US consulting firm Nuvera LLC

FDA clears Myovant's relugolix for uterine fibroids, setting...

Myovant has chalked up a second approval for its flagship drug relugolix from the FDA, becoming the first once-daily oral drug in the US to treat heavy menstrual bleeding associated with ut

Vectura agrees $1.4bn takeover by private equity group Carly...

Vectura has agreed to a £1.55 per share takeover by US private investment company Carlyle, which values the UK drug delivery specialist at £958 million ($1.4 billion). 

EU asks court to fine AstraZeneca over missing COVID jab shi...

Lawyers for the European Commission asked a court in Brussels today to fine AstraZeneca millions of euros for its "obvious"  failure to meet the terms of its contract to supply COVID-1